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Detailed mechanistic studies of lipases and phospholipases
are hampered by poorly defined surfaces. In particular,
manipulation of lipid component concentrations can
drastically affect particle structure and/or enzymatic
activity. Short-chain lecithin molecules are a particularly
useful building block of complex but characterizable
micellar particles. These lecithins, with four to eight
carbons in the fatty acyl chains, exist as monomers in
aqueous solution and form micelles above a critical micelle
concentration (c.m.c.). Their detergent properties allow
them to solubilize large fractions of lipophilic substances
such as triglycerides (0.5 mol fraction) and cholesterol
(0.18 mol fraction). We have used 13C NMR spectroscopy
of these lecithins to (a) examine the conformation and
motion of individual sn-I /sn-2 chains for monomeric and
micellar lecithin; (b) assess the conformational effects of
chemical changes in the lecithin molecule; and (c) charac-
terize mixed particles consisting of short-chain lecithins,
triglyceride and/or cholesterol that mimic lipoprotein
structure. The characterized particles are then used in
kinetic studies of lipolytic enzymes.
RESULTS
In contrast to results with long-chain lecithins, all carbons
are resolved in the `3C NMR spectra (1). The extent of
sn-l/sn-2 chain carbon magnetic nonequivalence reflects
the aggregation state of the short-chain lecithin. Motional
gradients of the fatty acyl chains in micellar lipid show
characteristics of lecithins in bilayers: a plateau of
"restricted" motion near the glyceryl backbone, then an
increased motion in the last two carbons. However, 13C
NMR and Raman temperature dependence studies show
that the individual molecules in the micelle are quite fluid
(2). The monomer-to-micelle 13C chemical shifts can be
understood as the result of a solvent change to a hydrogen-
bond donor-deficient environment with only a slight
increase in trans conformers (5-7%) and possibly a small
conformational change in the glyceryl backbone. This
picture is useful in eliminating several explanations for the
interfacial activation characteristics of soluble phospholi-
pases.
The substitution of an ether for an ester linkage yields a
lecithin analogue with a slightly lower c.m.c. but similar
conformation (3) as judged by NMR parameters. There-
fore, ether and ester lipids form an ideal mixed micelle
system for kinetic analyses of phospholipases. Our kinetics
(Table I) show that ether lecithins are good inhibitors of
phospholipase A2 (Naja naja naja), but are neither
substrate nor inhibitor for phospholipase C (Bacillus
cereus). As well as indicating that the carbonyl ester is an
important binding determinant for phospholipase C, this
result makes mixed micelles of short-chain ester and ether
lecithins useful for studies of surface dilution effects
without complications of dilutor-enzyme interactions.
Short-chain lecithin mixed micelles with triglyceride
(4) are substrates for pancreatic lipase. By proper choice
of triglyceride and lecithin chain lengths all chain carbon
atoms in mixed particles can be observed in the '3C NMR
spectra; hence motions of each component can be investi-
gated. NMR and phospholipase kinetics suggest that the
triglyceride is mostly in a core surrounded by phospholi-
pid. Lipase hydrolysis rates of the triglyceride in these
small, relatively homogeneous particles are 0.3-0.5 times
those of triglyceride emulsions alone. Once sufficient leci-
thin is added to solubilize the triglyceride, the reaction rate
becomes independent of the lecithin:triglyceride ratio.
This particle-specific activity depends on both triglyceride
TABLE I
PHOSPHOLIPASE ACTIVITY TOWARD 5mM
DIHEPTANOYL-PC (DiC7PC) AND MIXED MICELLES
WITH DIHEPTYL-PC (e-PC)
Sample Phospholipase-A2 Phospholipase-C
(Mmole min-'mg-')
DiC7PC (5mM) 213(3) 1650(90)
+e-PC (2mM) 81(2) 2000(240)
+e-PC (5mM) 46(3) 1560(10)
e-PC (5mM) 0 <3
TABLE II
PANCREATIC LIPASE ACTIVITY AGAINST OPTICALLY
CLEAR SHORT-CHAIN LECITHIN/TRIGLYCERIDE
PARTICLES
Sample* Particle specific activity
(Mmole min-'mg-I)
DiC6PC/TB 53(1)
DiC7PC/TB 70(1)
DiC8PC/TB 97(9)
TB emulsion 210(40)
DiC7PC/TH 18(1)
DiCgPC/TH 10(0.1)
TH emulsion 34(13)
*Assays contain 5mM TB (tributyrin) or TH (trihexanoin), 5mM
CaC12.
105BIOPHYS. J. © Biophysical Society - 0006-3495/82/01/105/02 $1.00
Volume 37 January 1982 105-106
and lecithin chain length (Table II). A detailed model is
proposed to account for this behavior.
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ASSEMBLY OF THE PROTHROMBINASE COMPLEX
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The term "prothrombinase" refers to the complex
composed of the enzyme Factor Xa, the cofactor protein
Factor Va, calcium ions and phospholipid, which is
thought to be responsible for the physiological conversion
of the zymogen prothrombin to the enzyme thrombin.
Although Factor Xa is sufficient for prothrombin activa-
tion, the cofactors increase the rate of thrombin generation
- 300,000-fold at plasma concentrations of enzyme and
substrate. Both the enzyme (Factor Xa) and the substrate
(prothrombin) of this reaction are vitamin K-dependent
proteins, each of which possesses y-carboxyglutamic acids
at the NH2 terminals of their respective peptide chains. As
a consequence of these residues, these proteins can, in the
presence of calcium, bind membranes containing acidic
phospholipids. The cofactor for the reaction, Factor Va, is
present in plasma in the form of a "pro" cofactor species,
Factor V. Limited proteolysis by thrombin converts the
"pro" cofactor, Factor V, to the active cofactor, Factor Va.
Current data suggest that Factor V possesses some mini-
mal level of activity, but that Factor Va is at least 400
times more active than the uncleaved Factor V.
The "pro" cofactor species, Factor V, is a rather
unusual plasma protein. It is a single-chain protein with a
molecular weight of 330,000 (1). Both sedimentation and
gel filtration analysis of Factor V suggest that the protein
is highly asymmetric. The sedimentation coefficient for
Factor V is - 9.2S and the Stokes Radius is 91-93 A (1,
2). Factor V possesses three binding sites for calcium, two
having dissociation constants of 6 x 10-5M, one of
< 10-8M (3). This very tightly-bound calcium appears to
have structural significance with respect to the ultimate
association of Factor Va polypeptide chains. Thrombin
cleaves Factor V at at least four points in the polypeptide
chain, leading to a Factor Va molecule composed of two to
three peptide units. Two peptides with molecular weights
of 94,000 and 74,000 are essential for the cofactor activity
present in Factor Va preparations (3, 4). A third peptide,
with a molecular weight 31,000, is also associated with the
Factor Va molecule, while two activation peptides with
apparent molecular weights 70,000 and 90,000 are not
associated with Factor Va. The treatment of Factor Va
with EDTA permits dissociation of the two essential
Factor Va chains (94,000 and 74,000), neither of which
possesses activity in its own right (5, 6). These chains can
be reassociated by the readdition of calcium ion. The
functions of the remaining polypeptide chains in Factor Va
have not yet been investigated. The Stokes Radius
obtained on gel filtration of Factor Va is - 51 A (2).
Both Factor V and Factor Va bind to phosphatidylchol-
ine-phosphatidylserine vesicles and to blood platelets (7,
8). In contrast to the vitamin K-dependent proteins, Factor
V binding to membranes is metal ion and ionic strength
independent. The activated cofactor binds to acidic phos-
pholipid-containing vesicles with approximately ten times
the affinity of either prothrombin or Factor Xa, and binds
to a limited number of sites on the platelet membranes
with a dissociation constant of 10-°0 M.
RESULTS AND DISCUSSION
We are examining the participation of each of the three
proteins, phospholipid and platelet membranes, and
calcium ions in the generation of thrombin from prothrom-
bin. Our approaches include equilibrium binding measure-
ments of each of the species in the reaction system, using
light scattering, fluorescence, and sedimentation tech-
niques, and studies of the conversion of prothrombin to
thrombin using both a synthetic substrate and prothrom-
'bin (9). In the latter case, the fluorescent inhibitor, dansy-
larginine N-(3-ethyl-1,5-pentanediyl)amide (DAPA) has
been used as a probe. This compound is a specific inhibitor
of thrombin (Kd = 4 x 10-8M) and binds reversibly at the
active site in 1:1 stoichiometry (10). The bound probe
exhibits fluorescence properties allowing for continuous
assessment of the formation of thrombin from a zymogen
prothrombin.
In addition to equilibrium studies of biomolecular
association processes, we have recently extended our stud-
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